North America

Vivify acquires AuNutra Industries ingredient platform

Vivify acquires AuNutra Industries ingredient platform

By Asia Sherman

Vivify Specialty Ingredients, a portfolio company of Gryphon Investors, acquired AuNutra Industries, a supplier of botanical extracts and specialty nutritional ingredients, as the private equity firm continues to expand its presence in the high-growth...

Bird&Be raises $13M to accelerate fertility expansion

Bird&Be raises $13M to accelerate fertility expansion

By Cassandra Stern

The round was led by BDC Thrive and BFG Partners, with backing from BAM Ventures, Founder Collective, Rejuvenation Ventures and HSR Ventures. The company reported nearly 100% year-over-year growth, with subscriptions accounting for 75% of revenue.

Andrew Shao receives 2026 Annette Dickinson Trailblazer Award

Andrew Shao receives 2026 Annette Dickinson Trailblazer Award

By Danielle Masterson

Andrew Shao, PhD, senior vice president of global scientific and regulatory affairs at Niagen Bioscience, has been named this year’s CRN/Radicle Science Anette Dickinson Trailblazer Award honoree, recognizing more than 25 years of scientific leadership...

2025 Start-Up Stars winner catch-up: The next chapter

2025 Start-Up Stars winner catch-up: The next chapter

By Cassandra Stern

Since winning NutraIngredients’ Start-up Stars competition in 2025, New History has expanded beyond its original nootropic pre-workout offering into functional hydration, launching its zero-sugar, non-carbonated beverage NH2O.

WIN brings four ingredient suppliers under one sachet

WIN brings four ingredient suppliers under one sachet

By Cassandra Stern

The RISE + RESTORE project combines branded ingredients from TSI Group, Stratum Nutrition, Nuritas and AstaReal in daytime energy and nighttime wellness supplement concepts with samples set for SupplySide Global 2026.

Magnesium and sleep: What does the science say?

NI+Magnesium and sleep: What does the science say?

By Lauren Nicolle

A recent systematic review of randomized controlled trials raises questions about magnesium’s effectiveness as a sleep aid, concluding that the current evidence is inconsistent and of low certainty.

Supplement sector rising, ‘safety needs to evolve with it’

NI+Supplement sector rising, ‘safety needs to evolve with it’

By Asia Sherman

Growing supplement use, novel ingredients, personalized nutrition and digital health advice are challenging safety frameworks in a fragmented global regulatory landscape, prompting greater discussion about the tools needed to foster regulatory coherence.

FDA, industry outline priorities for dietary supplement modernization

FDA, industry outline priorities for dietary supplement modernization

By Danielle Masterson

As the US Food and Drug Administration (FDA) considers how to modernize dietary supplement oversight, Cara Welch, PhD, director of FDA’s Office of Dietary Supplement Programs, has emphasized the agency’s commitment to keeping pace with an evolving...

Inside the consumer challenges fueling the omega-3 gap

Inside the consumer challenges fueling the omega-3 gap

By Cassandra Stern

Consumer data shows consumers may already know omega-3s matter. Getting them to understand which omega-3s they need, choose a product or food source and stick with it is proving to be a different challenge.

Drug Preclusion: Necessary Reform

Opinion piece

Drug Preclusion: Necessary Reform

By Steve Mister, President & CEO, Council for Responsible Nutrition & Graham Rigby, President & CEO, American Herbal Products Association

Industry agrees that drug preclusion is broken and in need of reform. We all saw what happened with NAC and NMN. And we want dietary supplement companies to have greater certainty before investing millions of dollars developing and marketing an ingredient.

Market Moves: Supplement industry deals of Q3 2026

NI+Market Moves: Supplement industry deals of Q3 2026

By Asia Sherman

Deal activity across the supplement and wider wellness sector remained brisk in the third quarter of 2026, with strategic buyers and private equity firms placing big bets on premium brands, science-led portfolios and scalable manufacturing platforms.

Drug preclusion: Consider the source

Opinion piece

Drug preclusion: Consider the source

By Daniel Fabricant, PhD, President and CEO, NPA

CRN, CHPA and AHPA are celebrating H.R. 10336 as a balanced compromise. But in the pursuit of regulatory certainty, has part of the supplement industry agreed to permanently enshrine the very pharmaceutical gatekeeping mechanism it has spent years fighting?

Start-Up Stars opens entries for 2027 summit

Start-Up Stars opens entries for 2027 summit

By Cassandra Stern

Three emerging sports and active nutrition companies will earn the chance to pitch their businesses, build industry connections and take the stage at the 2027 summit.

Beyond fish oil: What could close the omega-3 gap?

Beyond fish oil: What could close the omega-3 gap?

By Cassandra Stern

The omega-3 industry has spent decades trying to close the gap between recommended and actual EPA and DHA intake. But with traditional marine resources under pressure, researchers are increasingly asking whether a broader mix of sources can close that gap.

SANS USA moves to Dallas for 2027

SANS USA moves to Dallas for 2027

By Cassandra Stern

The Sports & Active Nutrition Summit USA (SANS USA) is heading to Dallas in 2027 after two consecutive sold-out editions in San Diego.

Functional super mushrooms: No longer a niche category

NI+Functional super mushrooms: No longer a niche category

By Rahul Roy, Director, Vitamin & Specialty Retail, SPINS

Functional mushrooms continue to evolve from a niche immune-support ingredient into the broader wellness ecosystem, spanning cognitive health, mood support, active nutrition, healthy aging and overall wellness.